We would like to keep you up to date with the latest news from Digitalisation World by sending you push notifications.
Digital Newsletter
Each week our editor Phil Alsop rounds up the most popular articles, videos and expert opinions. We compile this into a Digital Newsletter and send it straight to your inbox every week.
Digital Magazines
We'll let you know each time a new edition of Digitalisation World is released so that you're always kept up-to-date with the latest and greatest news and press releases.
Video Magazines
The Digitalisation World Video magazine contains the latest Zoom interviews with experts in the industry.
The data challenge is specifically focused on testing the relationships between COVID-19 and other health conditions, as well as health disparities and social determinants of health that bring a higher burden of illness or mortality based on factors such as ethnicity, gender, geography or income.
BurstIQ’s global COVID-19 datasets will be available on the American Heart Association’s Precision Medicine Platform, a central hub to the cardiovascular and stroke research community with vast and diverse datasets and cloud-based workspaces that enable state-of-the-art high-performance computing, analytics and collaboration to accelerate scientific discovery. Through the data challenge, COVID-19 researchers will be able to utilize the Platform’s protected workspaces, which are equipped with state-of-the-art analytical tools, machine learning and artificial intelligence. Researchers may use datasets hosted on the Platform as well as their own data to address the unsolved questions of how COVID-19 may be disproportionally affecting those with health disparities.
“People living in under-resourced communities, particularly African Americans and U.S. Hispanics, appear to be dying of COVID-19 at disproportionately high rates, as they’re more likely to have underlying health conditions such as high blood pressure, diabetes, heart disease and obesity,” said Jennifer Hall, Ph.D., chief of data science for the American Heart Association. “Long before the pandemic, systemic challenges have contributed to disparities that impede some people from living long, healthy lives. COVID-19 has further exacerbated this issue.”
Hitachi Vantara, which built the American Heart Association’s Precision Medicine Platform, will provide more than $100,000 in funding for prizes to support the management of a two-step challenge and to recruit top scientists to this critical effort. Six $5,000 prizes will be awarded at the end of stage one. These researchers will then compete in a final stage for a $15,000 prize. All applications will be peer reviewed by a panel of data science and public health experts.
“Improving collaboration around data between researchers and scientists enables the rapid co-creation of new solutions that more quickly and effectively tackle existing and new healthcare threats such as COVID-19,” said Paul Watson, vice president Healthcare & Life Sciences, Hitachi Vantara. “Working together our three organizations will deliver a paradigm shift in the way researchers and their institutions leverage data to solve medical challenges like COVID-19.”
“The entire world is facing an unprecedented challenge with COVID-19,” said Frank Ricotta, CEO, BurstIQ. “Our collaboration with the American Heart Association and Hitachi Vantara on this data challenge allows the research community to truly accelerate the pace of COVID-19 research, and as a collaborative network, it will have a long-lasting impact not just for COVID-19, but far beyond.”
